Black Rock Inc. Cara Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,421,363 shares of CARA stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,421,363

Previous 3,554,258 3.74%

Holding current value

$2.22 Million

Previous $2.63 Million 18.37%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.52 - $1.05 $69,105 - $139,539	-132,895 Reduced 3.74%	3,421,363 $3.11 Million
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.65 $92,305 - $253,840	-153,843 Reduced 4.15%	3,554,258 $2.63 Million
Q3 2023 Nov 13, 2023	BUY	$1.67 - $3.33 $10,242 - $20,422	6,133 Added 0.17%	3,708,101 $6.23 Million
Q2 2023 Aug 11, 2023	SELL	$2.83 - $4.94 $11 Million - $19.3 Million	-3,900,715 Reduced 51.31%	3,701,968 $10.5 Million
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $635,929 - $1.6 Million	-130,047 Reduced 1.68%	7,602,683 $37.3 Million

Q4 2022 Feb 13, 2023	BUY	$8.88 - $12.77 $1.34 Million - $1.92 Million	150,436 Added 1.98%	7,732,730 $83 Million
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $1.89 Million - $2.88 Million	229,507 Added 3.12%	7,582,294 $71 Million
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $1.23 Million - $2.29 Million	165,663 Added 2.3%	7,352,787 $67.1 Million
Q1 2022 May 12, 2022	SELL	$9.94 - $12.65 $119,299 - $151,825	-12,002 Reduced 0.17%	7,187,124 $87.3 Million
Q4 2021 Feb 10, 2022	BUY	$11.99 - $18.14 $1.12 Million - $1.7 Million	93,737 Added 1.32%	7,199,126 $87.7 Million
Q3 2021 Nov 09, 2021	SELL	$11.55 - $16.06 $2.2 Million - $3.06 Million	-190,679 Reduced 2.61%	7,105,389 $110 Million
Q2 2021 Aug 11, 2021	BUY	$12.38 - $29.19 $90.3 Million - $213 Million	7,296,068 New	7,296,068 $104 Million

Others Institutions Holding CARA

# of Institutions

101

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $34.9M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account